Altos Labs, founded in 2021, is a pioneering biotechnology company committed to deciphering the underlying biology of cell rejuvenation with the aim of reversing disease. Operating predominantly in the San Francisco Bay Area, San Diego, and Cambridge, UK, the company brings together an interdisciplinary team of top-tier scientists and clinicians.
With a focus on the Biopharma, Biotechnology, and Health Care industries, Altos Labs is positioned at the cutting edge of medical innovations designed to foster cell health and resilience. Their approach underscores a potential shift in how chronic conditions are treated, emphasizing prevention and reversal rather than management.
The last significant investment, a substantial $3.00B Early VC round, occurred on 01 January 2022, led by Bezos Expeditions. This backing not only highlights the strategic interest of high-profile investors but also reinforces confidence in Altos Labs' revolutionary pursuits in biotechnology research.
